Concerning the lawful use of a prescription drug that contains 3,4-methylenedioxymethamphetamine (MDMA) that is approved by the United States food and drug administration.
Concerning changes to medicaid to allow for expedited repairs to complex rehabilitation technology, and, in connection therewith, making an appropriation.
Concerning the continuation of the regulation of conveyances, and, in connection therewith, implementing the recommendations contained in the 2021 sunset report by the department of regulatory agencies.